cbdMD, Inc. (NYSEAMERICAN:YCBD) Short Interest Down 13.1% in June

cbdMD, Inc. (NYSEAMERICAN:YCBD) saw a large decline in short interest in the month of June. As of June 15th, there was short interest totalling 142,300 shares, a decline of 13.1% from the May 31st total of 163,700 shares. Approximately 4.5% of the shares of the company are sold short. Based on an average daily volume of 198,300 shares, the short-interest ratio is presently 0.7 days.

Institutional Investors Weigh In On cbdMD

A hedge fund recently raised its stake in cbdMD stock. AXS Investments LLC grew its stake in shares of cbdMD, Inc. (NYSEAMERICAN:YCBD) by 42.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 91,204 shares of the company’s stock after buying an additional 27,017 shares during the period. AXS Investments LLC owned 2.99% of cbdMD worth $95,000 at the end of the most recent reporting period. 7.18% of the stock is owned by institutional investors.

cbdMD Trading Up 2.1 %

NYSEAMERICAN YCBD opened at $0.59 on Friday. The firm has a market cap of $2.28 million, a PE ratio of -0.05 and a beta of 1.99. cbdMD has a one year low of $0.56 and a one year high of $1.73. The company has a current ratio of 1.07, a quick ratio of 0.61 and a debt-to-equity ratio of 0.88.

cbdMD (NYSEAMERICAN:YCBD) last announced its quarterly earnings data on Wednesday, May 15th. The company reported ($1.35) earnings per share (EPS) for the quarter. cbdMD had a negative net margin of 102.25% and a negative return on equity of 193.04%. The firm had revenue of $4.82 million during the quarter.

About cbdMD

cbdMD, Inc produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids.